BORTEZOMIB AND PEGYLATED LIPOSOMAL DOXORUBICIN AS THERAPY FOR MULTIPLE MYELOMA

硼替佐米和聚乙二醇化脂质体阿霉素治疗多发性骨髓瘤

• 批准号: 7625591
• 负责人: ROBERT ZYGMUNT ORLOWSKI
• 金额: $ 0.66万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625591
• 关键词: Bortezomib; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Multiple Myeloma; Pharmaceutical Preparations; Purpose; Research; Research Personnel; Resources; Source; Sterically Stabilized Liposome; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to find out what effects (good and bad) the drugs Bortezomib and pegylated liposomal doxorubicin have on multiple myeloma.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究的目的是找出药物硼替佐米和聚乙二醇脂质体阿霉素对多发性骨髓瘤的影响（好的和坏的）。